Global Innovative Platforms (GIPL) Change in Account Payables (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Change in Account Payables came in at -$109.0 in Q2 2026, down 113.81% year-over-year from $789.0 in Q2 2025, and down 162.29% quarter-over-quarter from $175.0 in Q4 2025.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Change in Account Payables (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Change in Account Payables across 7 years of filings, most recently posting -$109.0 for Q2 2026.
- In Q2 2026, Change in Account Payables fell 113.81% year-over-year to -$109.0; the TTM figure through Jun 2026 stood at -$2648.0 (up 83.69% YoY), while the FY2025 annual figure was -$644.0, up 71.39% from the prior year.
- Change in Account Payables came in at -$109.0 for Q2 2026 at Global Innovative Platforms, down from $175.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $13654.0 in Q4 2024 to a low of -$18301.0 in Q3 2024.
- Average Change in Account Payables over 5 years is -$656.47, with a median of -$109.0 recorded in 2026.
- Year-over-year, Change in Account Payables jumped 723.16% in 2024 and slumped 1053.97% in 2025.
- Over 5 years, Change in Account Payables stood at $3959.0 in 2022, then jumped by 123.11% to $8833.0 in 2023, then jumped by 54.58% to $13654.0 in 2024, then plunged by 98.72% to $175.0 in 2025, then tumbled by 162.29% to -$109.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$109.0 in Q2 2026, $175.0 in Q4 2025, and -$2714.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -6.74 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -53.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -5.65 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -109.00 |
| Dec 31, 2025 | 175.00 |
| Sep 30, 2025 | -2,714.00 |
| Jun 30, 2025 | 789.00 |
| Mar 31, 2025 | -12,373.00 |
| Dec 31, 2024 | 13,654.00 |
| Sep 30, 2024 | -18,301.00 |
| Jun 30, 2024 | 5,920.00 |
| Mar 31, 2024 | 1,297.00 |
| Dec 31, 2023 | 8,833.00 |
| Sep 30, 2023 | -2,244.00 |
| Jun 30, 2023 | -950.00 |
| Mar 31, 2023 | -2,772.00 |
| Dec 31, 2022 | 3,959.00 |
| Sep 30, 2022 | -6,516.00 |
| Jun 30, 2022 | 609.00 |
| Mar 31, 2022 | -417.00 |
| Dec 31, 2021 | 6,520.00 |
| Sep 30, 2021 | -1,946.00 |
| Jun 30, 2021 | 3,000.00 |